K Number
K971526
Device Name
ACE HDL-C REAGENT
Date Cleared
1997-05-21

(23 days)

Product Code
Regulation Number
862.1475
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
This in vitro diagnostic product is intended for the quantitative determination of HDL cholesterol in human serum. Numerous studies have shown an inverse relationship between serum HDL cholesterol and the risk of coronary heart disease. HDL cholesterol also has an important role in the pathogenesis of atherosclerosis.
Device Description
An aliquot of serum is added to the first reagent which contains a mixture of polymers and polyanions that bind to the surface of low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and chylomicrons. These complexed lipoproteins are stabilized, even in the presence of detergent, which is added as part of the second reagent, together with cholesterol enzymes. HDL particles are not stabilized by the polymers and polyanions and become solubilized by the detergent. As a result, only the HDL cholesterol is subject to measurement.
More Information

Not Found

No
The device description details a chemical assay for measuring HDL cholesterol, and there is no mention of AI or ML in the provided text.

No.
This device is an in vitro diagnostic product intended for the quantitative determination of HDL cholesterol in human serum, which is used for diagnosis, not treatment.

Yes

The "Intended Use / Indications for Use" section explicitly states, "This in vitro diagnostic product is intended for the quantitative determination of HDL cholesterol in human serum." The term "in vitro diagnostic product" directly indicates it is a diagnostic device.

No

The device description clearly outlines a chemical assay involving reagents and serum, indicating a hardware component (likely a laboratory analyzer) is required for its function, not just software.

Yes, this device is an IVD (In Vitro Diagnostic).

The "Intended Use / Indications for Use" section explicitly states: "This in vitro diagnostic product is intended for the quantitative determination of HDL cholesterol in human serum."

This statement clearly identifies the device as an in vitro diagnostic product.

N/A

Intended Use / Indications for Use

ACE™ HDL-C Reagent is intended for use in the quantitative determination of HDL cholesterol in human serum.
This in vitro diagnostic product is intended for the quantitative determination of HDL cholesterol in human serum.

Product codes (comma separated list FDA assigned to the subject device)

LBS, JIX, JJY

Device Description

An aliquot of serum is added to the first reagent which contains a mixture of polymers and polyanions that bind to the surface of low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and chylomicrons. These complexed lipoproteins are stabilized, even in the presence of detergent, which is added as part of the second reagent, together with cholesterol enzymes. HDL particles are not stabilized by the polymers and polyanions and become solubilized by the detergent. As a result, only the HDL cholesterol is subject to measurement.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical test results submitted in the premarket notification include within-run and between run precision and method correlation.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Assay Range: 2 mg/dL to 100 mg/dL
Precision - Within Run:

§ 862.1475 Lipoprotein test system.

(a)
Identification. A lipoprotein test system is a device intended to measure lipoprotein in serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.

0

510(k) PREMARKET NOTIFICATION Summary of Safety and Effectiveness ACE™ HDL-C Reagent

K971526

In lieu of a 510(k) statement under 513(i) of the Act, this Summary of Safety and Effectiveness is tur nou of a S10(k) summary for disclosure to any other persons / companies without specific written authorization from Schiapparelli Biosystems, Inc.

Submitter

Schiapparelli Biosystems, Inc. 368 Passaic Avenue Fairfield, NJ 07004 Phone: (201) 882-8630

Contact Person

Steve Dalessio Manager. Quality Assurance and Regulatory Affairs Phone: (201) 882-8630

Device Names

ACE™ HDL-C Reagent Proprietary Name: Homogeneous assay for high density lipoprotein cholesterol Common Name: Classification Name: High density lipoprotein cholesterol test

Predicate Device

Genzyme Corporation's - N-geneous™ HDL Cholesterol Reagent [510(k) Number K962186]

Device Description

An aliquot of serum is added to the first reagent which contains a mixture of polymers and polyanions that bind to the surface of low-density lipoproteins (LDL), very low-density lipoproteins (VLDL) and chylomicrons. These complexed lipoproteins are stabilized, even in the presence of detergent, which is added as part of the second reagent, together with cholesterol enzymes. HDL particles are not stabilized by the polymers and polyanions and become solubilized by the detergent. As a result, only the HDL cholesterol is subject to measurement.

Intended Use of the Device

ACE™ HDL-C Reagent is intended for use in the quantitative determination of HDL cholesterol in human serum.

HHDL510K.WPS

Image /page/0/Picture/17 description: The image shows the date May 21, 1997. The month is written in all caps, and the day and year are written in numerals. The text is written in a bold, sans-serif font. The image is a close-up of the date, and the background is white.

1

Summary of Safety and Effectiveness ACE™ HDL-C Reagent

COMPARATIVE FEATURES OF PREDICATE AND PROPOSED DEVICE

PARAMETERPREDICATE DEVICEPROPOSED DEVICE
Trade NameN-geneous TM HDL
CholesterolACE TM HDL-C Reagent
Reference No.K962186TBD
AnalyteHDL CholesterolHDL Cholesterol
Intended UseQuantitative determination
of HDL CholesterolQuantitative determination
of HDL Cholesterol
MethodologyHomogeneous; DirectHomogeneous; Direct
Reagents
Reagent 1Liquid; Polyanion, PolymerLiquid; Polyanion, Polymer
Volume300 uL300 uL
Reagent 2 (Diluent)Liquid; DetergentLiquid; Detergent
Reagent 3 (Recon with Rgt 2)Lyophilized; EnzymesLyophilized; Enzymes
Volume100 uL100 uL
Specimen
TypeSerum and PlasmaSerum
Volume3 uL3 uL
Assay System
Reagent 1 + sampleIncubate 300sIncubate 300s
Reagent 3Incubate 24 - 300sIncubate 300s
Temperature37C37C
Detection Method
TypeSpectrophotometricSpectrophotometric
Wavelength, nmBichromatic: 546/660Bichromatic: 544/692

HHDL510K.WPS

-7-

2

Summary of Safety and Effectiveness ACETM HDL-C Reagent

Performance Assessment

Non-clinical test results submitted in the premarket notification include within-run and between run precision and method correlation. Following is a data summary.

PARAMETERPREDICATE DEVICEPROPOSED DEVICE
Performance Summary
Assay Range2 mg/dL to 200 mg/dL2 mg/dL to 100 mg/dL
Precision
Within Run301 594 5941

Page 1 of 1

510(k) Number (if known):_

Device Name:_ACE HDL-C REAGENT

Indications For Use:

This in vitro diagnostic product is intended for the quantitative determination of HDL cholesterol in human serum.

Numerous studies have shown an inverse relationship between serum HDL cholesterol and the risk of coronary heart disease. HDL cholesterol also has an important role in the pathogenesis of atherosclerosis.

signature

(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number K971526

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use) (Per 21 CFR 801.109)

: "

Article Carante

OR

Over-The-Counter Use_

(Optional Format 1-2-96)